Treanda Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)
Conditions:   Chronic Lymphocytic Leukemia;   Small Lymphocytic Leukemia Interventions:   Drug: Nemtabrutinib;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Bendamustine;   Biological: Rituximab;   Biological: Rituximab biosimilar Sponsor:   Merck Sharp & Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2022 Category: Research Source Type: clinical trials